Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant

Abstract

Adgrg6 (Gpr126) is an adhesion class G protein-coupled receptor with a conserved role in myelination of the peripheral nervous system. In the zebrafish, mutation of adgrg6 also results in defects in the inner ear: otic tissue fails to down-regulate versican-gene expression and morphogenesis is disrupted. We have designed a whole-animal screen that tests for rescue of both up- and down-regulated gene expression in mutant embryos, together with analysis of weak and strong alleles. From a screen of 3120 structurally diverse compounds, we have identified 68 that reduce versican-b expression in the adgrg6 mutant ear, 41 of which also restore myelin basic protein gene expression in Schwann cells of mutant embryos. Nineteen compounds unable to rescue a strong adgrg6 allele provide candidates for molecules that may interact directly with the Adgrg6 receptor. Our pipeline provides a powerful approach for identifying compounds that modulate GPCR activity, with potential impact for future drug design.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Table 1 and Figure1-figure supplement 1, Figure 3, Figure 7 and Figure 7-figure supplements. Links to interactive files are given in the manuscript and in a supplemental file.

Article and author information

Author details

  1. Elvira Diamantopoulou

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9336-7965
  2. Sarah Baxendale

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6760-9457
  3. Antonio de la Vega de León

    Information School, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  4. Anzar Asad

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  5. Celia J Holdsworth

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  6. Leila Abbas

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  7. Valerie J Gillet

    Information School, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    No competing interests declared.
  8. Giselle R Wiggin

    Sosei Heptares, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  9. Tanya T Whitfield

    Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom
    For correspondence
    t.whitfield@sheffield.ac.uk
    Competing interests
    Tanya T Whitfield, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1575-1504

Funding

Biotechnology and Biological Sciences Research Council (Project grant BB/J003050/1)

  • Sarah Baxendale
  • Tanya T Whitfield

University of Sheffield (PhD studentship 314420)

  • Tanya T Whitfield

Medical Research Council (G0802527)

  • Sarah Baxendale
  • Celia J Holdsworth
  • Leila Abbas
  • Tanya T Whitfield

European Union's Seventh Framework Programme (Grant agreement no. 612347)

  • Valerie J Gillet

Biotechnology and Biological Sciences Research Council (BB/R50581X/1)

  • Sarah Baxendale
  • Anzar Asad
  • Giselle R Wiggin
  • Tanya T Whitfield

Wellcome (VIP award 084551)

  • Leila Abbas
  • Tanya T Whitfield

Medical Research Council (G0700091)

  • Sarah Baxendale
  • Celia J Holdsworth
  • Leila Abbas
  • Tanya T Whitfield

Biotechnology and Biological Sciences Research Council (Project grant BB/M01021X/1)

  • Sarah Baxendale
  • Tanya T Whitfield

Biotechnology and Biological Sciences Research Council (ALERT14 equipment award BB/M012522/1)

  • Sarah Baxendale
  • Tanya T Whitfield

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal work was performed under licence from the UK Home Office (P66302E4E), and approved by the University of Sheffield Ethical Review Committee (ASPA Ethical Review Process).

Copyright

© 2019, Diamantopoulou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,774
    views
  • 342
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elvira Diamantopoulou
  2. Sarah Baxendale
  3. Antonio de la Vega de León
  4. Anzar Asad
  5. Celia J Holdsworth
  6. Leila Abbas
  7. Valerie J Gillet
  8. Giselle R Wiggin
  9. Tanya T Whitfield
(2019)
Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant
eLife 8:e44889.
https://doi.org/10.7554/eLife.44889

Share this article

https://doi.org/10.7554/eLife.44889

Further reading

    1. Developmental Biology
    Michele Bertacchi, Gwendoline Maharaux ... Michèle Studer
    Research Article Updated

    The morphogen FGF8 establishes graded positional cues imparting regional cellular responses via modulation of early target genes. The roles of FGF signaling and its effector genes remain poorly characterized in human experimental models mimicking early fetal telencephalic development. We used hiPSC-derived cerebral organoids as an in vitro platform to investigate the effect of FGF8 signaling on neural identity and differentiation. We found that FGF8 treatment increases cellular heterogeneity, leading to distinct telencephalic and mesencephalic-like domains that co-develop in multi-regional organoids. Within telencephalic regions, FGF8 affects the anteroposterior and dorsoventral identity of neural progenitors and the balance between GABAergic and glutamatergic neurons, thus impacting spontaneous neuronal network activity. Moreover, FGF8 efficiently modulates key regulators responsible for several human neurodevelopmental disorders. Overall, our results show that FGF8 signaling is directly involved in both regional patterning and cellular diversity in human cerebral organoids and in modulating genes associated with normal and pathological neural development.

    1. Developmental Biology
    Shannon H Carroll, Sogand Schafer ... Eric C Liao
    Research Article

    Wnt signaling plays crucial roles in embryonic patterning including the regulation of convergent extension (CE) during gastrulation, the establishment of the dorsal axis, and later, craniofacial morphogenesis. Further, Wnt signaling is a crucial regulator of craniofacial morphogenesis. The adapter proteins Dact1 and Dact2 modulate the Wnt signaling pathway through binding to Disheveled. However, the distinct relative functions of Dact1 and Dact2 during embryogenesis remain unclear. We found that dact1 and dact2 genes have dynamic spatiotemporal expression domains that are reciprocal to one another suggesting distinct functions during zebrafish embryogenesis. Both dact1 and dact2 contribute to axis extension, with compound mutants exhibiting a similar CE defect and craniofacial phenotype to the wnt11f2 mutant. Utilizing single-cell RNAseq and an established noncanonical Wnt pathway mutant with a shortened axis (gpc4), we identified dact1/2-specific roles during early development. Comparative whole transcriptome analysis between wildtype and gpc4 and wildtype and dact1/2 compound mutants revealed a novel role for dact1/2 in regulating the mRNA expression of the classical calpain capn8. Overexpression of capn8 phenocopies dact1/2 craniofacial dysmorphology. These results identify a previously unappreciated role of capn8 and calcium-dependent proteolysis during embryogenesis. Taken together, our findings highlight the distinct and overlapping roles of dact1 and dact2 in embryonic craniofacial development, providing new insights into the multifaceted regulation of Wnt signaling.